TG Therapeutics, Inc.
IT ˙ BIT ˙ US88322Q1085
34,00 € 0,00 (0,00%)
2026-06-05
DEL PRIS
SecurityIT:1TGTX / TG Therapeutics, Inc.
InstitutionAmalgamated Bank
Latest Disclosed Ownership39,428 shares
Latest Disclosed Value $ 1,310
Amalgamated Bank reports 0.74% decrease in ownership of 1TGTX / TG Therapeutics, Inc.

On May 8, 2026 - Amalgamated Bank filed a 13F-HR form disclosing ownership of 39,428 shares of TG Therapeutics, Inc. (IT:1TGTX) valued at $1,090,578 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 5, 2026 disclosing 39,722 shares of TG Therapeutics, Inc.. This represents a change in shares of -0.74% during the quarter. The current value of the position is $1,340,552 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F TG THERAPEUTICS COM 88322Q108 39,428 -294 -0.74 1 0.00 0.0100
2026-02-05 2025-12-31 13F TG THERAPEUTICS COM 88322Q108 39,722 474 1.21 1 0.00 0.0085
2025-10-29 2025-09-30 13F TG THERAPEUTICS COM 88322Q108 39,248 424 1.09 1 0.00 0.0101
2025-08-04 2025-06-30 13F TG THERAPEUTICS COM 88322Q108 38,824 501 1.31 1 0.00 0.0108
2025-04-25 2025-03-31 13F TG THERAPEUTICS COM 88322Q108 38,323 -1,082 -2.75 2 0.00 0.0129
2025-02-04 2024-12-31 13F TG THERAPEUTICS COM 88322Q108 39,405 -123 -0.31 1 0.0097
2024-10-30 2024-09-30 13F TG THERAPEUTICS COM 88322Q108 39,528 34,660 712.00 1 0.0076
2024-08-12 2024-06-30 13F TG THERAPEUTICS COM 88322Q108 4,868 310 6.80 0 0.0007
2024-04-23 2024-03-31 13F TG THERAPEUTICS COM 88322Q108 4,558 -15,241 -76.98 0 0.0006
2024-02-06 2023-12-31 13F TG THERAPEUTICS COM 88322Q108 19,799 -916 -4.42 0 0.0027
2023-11-08 2023-09-30 13F TG THERAPEUTICS COM 88322Q108 20,715 0 0.00 0 0.0015
2023-08-11 2023-06-30 13F TG THERAPEUTICS COM 88322Q108 20,715 1,833 9.71 1 0.0042
2023-05-02 2023-03-31 13F TG THERAPEUTICS COM 88322Q108 18,882 -2,316 -10.93 0 0.0024
2023-02-10 2022-12-31 13F TG THERAPEUTICS COM 88322Q108 21,198 0 0.00 0 -100.00 0.0022
2022-11-09 2022-09-30 13F TG THERAPEUTICS COM 88322Q108 21,198 340 1.63 125 40.45 0.0012
2022-08-15 2022-06-30 13F TG THERAPEUTICS COM 88322Q108 20,858 -262 -1.24 89 -55.72 0.0008
2022-08-25 2022-03-31 13F/A-1 TG THERAPEUTICS COM 88322Q108 21,120 -1,602 -7.05 201 -53.47 0.0016
2022-06-30 2022-03-31 13F TG THERAPEUTICS COM 88322Q108 21,120 -1,602 201 0.0016
2022-02-15 2021-12-31 13F/A-1 TG THERAPEUTICS COM 88322Q108 22,722 -81 -0.36 432 -43.08 0.0032
2022-02-15 2021-12-31 13F TG THERAPEUTICS COM 88322Q108 22,722 -81 432 0.0032
2021-10-29 2021-09-30 13F TG THERAPEUTICS COM 88322Q108 22,803 -1,403 -5.80 759 -19.17 0.0064
2021-08-16 2021-06-30 13F TG THERAPEUTICS COM 88322Q108 24,206 7,982 49.20 939 20.08 0.0075
2021-05-13 2021-03-31 13F TG THERAPEUTICS COM 88322Q108 16,224 -612 -3.64 782 -10.73 0.0293
2021-02-12 2020-12-31 13F TG THERAPEUTICS COM 88322Q108 16,836 693 4.29 876 102.78 0.0332
2020-10-30 2020-09-30 13F TG THERAPEUTICS COM 88322Q108 16,143 1,722 11.94 432 53.74 0.0188
2020-08-10 2020-06-30 13F TG THERAPEUTICS COM 88322Q108 14,421 -145 -1.00 281 96.50 0.0130
2020-05-13 2020-03-31 13F TG THERAPEUTICS COM 88322Q108 14,566 -729 -4.77 143 -15.88 0.0035
2020-02-13 2019-12-31 13F TG THERAPEUTICS COM 88322Q108 15,295 1,633 11.95 170 120.78 0.0031
2019-11-13 2019-09-30 13F TG THERAPEUTICS COM 88322Q108 13,662 -107 -0.78 77 -35.29 0.0016
2019-08-14 2019-06-30 13F TG THERAPEUTICS COM 88322Q108 13,769 13,769 119 0.0028
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.